References
- Callis A. H., Brooks S. D., Waters S. J., Lucas D. O., Gandolfi A. J., Sipes I. G., Satoh H., Pohl L. R. Evidence for a role of the immune system in the pathogenesis of halothane hepatitis. Molecular and Cellular Mechanisms of Anesthetics, S. H. Roth, K. W. Miller. Raven Press, New York 1986; 443
- Hubbard A. K., Roth T. P., Gandolfi A. J., Brown B. R., Jr., Webster N. R., Nunn J. F. Halothane hepatitis patients generate an antibody response toward a covalently bound metabolite of halothane. Anesthesiology 1988; 68: 791
- Satoh H., Fukuda Y., Anderson D. K., Ferrans V. J., Gillette J. R., Pohl L. R. Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. J. Pharmac. Exp. Ther. 1985; 233: 857
- Neuberger J., Kenna J. G. Halothane hepatitis: A model of immune mediated drug hepatotoxicity. Clin. Sci. 1987; 72: 263
- Kenna J. G., Satoh H., Christ D. D., Pohl L. R. Metabolic basis for a drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J. Pharmac. Exp. Ther. 1988; 245: 1103
- Roth T. P., Hubbard A. K., Gandolfi A. J., Brown B. R. Chronology of halothane-induced antigen in situ by specific anti-halothane metabolite antibodies. Clin. Exp. Immun. 1988; 72: 330
- Hubbard A. K., Roth T. P., Schuman S., Gandolfi A. J. Localization of halothane-induced antigen in situ by specific anti-halothane metabolite antibodies. Clin. Exp. Immun. 1989; 76: 422
- Brown A. P., Hastings K. L., Gandolfi A. J., Brendel K. Covalent binding of a halothane metabolite and neoantigen production in guinea pig liver slices. Biological Reactive Intermediates IV, C. M. Witmer, et al. Plenum Press, New York 1991; 693
- Pohl L. R., Kenna J. G., Satoh H., Christ D., Martin J. L. Neoantigens associated with halothane hepatitis. Drug Metab. Rev. 1989; 20: 203
- Callis A. H., Brooks S. D., Roth T. P., Gandolfi A. J., Brown B. R. Characterization of a halothane-induced humoral immune response in rabbits. Clin. Exp. Immun. 1987; 67: 343
- Siadat-Pajouh M., Hubbard A. K., Roth T. P., Gandolfi A. J. Generation of halothane-induced immune response in a guinea pig model of halothane hepatitis. Anesth. Analg. 1987; 66: 1209
- Farrell G. C. Mechanism of halothane-induced liver injury: Is it immune or metabolic idiosyncrasy. J. Gastroenterol. Hepatol. 1988; 3: 465
- Neuberger J. M., Kenna J. G., Williams R. Halothane hepatitis: Attempt to develop an animal model. Int. J. Immunopharmac. 1987; 9: 123
- Lind R. C., Gandolfi A. J., Hall P. M. The role of oxidative biotransformation of halothane in the guinea pig model of halothane-associated hepatotoxicity. Anesthesiology 1989; 70: 649
- Ghantous H. N., Fernando J., Gandolfi A. J., Brendel K. Biotransformation of halothane in guinea pig liver slices. Drug Metab. Dispos. 1990; 18: 514
- Goldberger R., Anfinsen C. The reversible masking of amino groups in ribonuclease and its possible usefulness in the synthesis of the protein. Biochemistry 1962; 1: 401
- Soltis J. J., Gandolfi A. J. Detection of fluorinated anesthetic metabolites by sodium fusion. Anesth. Analg. 1980; 59: 61
- Kenna J. G., Major G. N., Williams R. S. Methods for reducing non-specific antibody binding in enzyme-linked immunosorbent assays. J. Immun. Methods 1985; 85: 409
- Lind R. C., Gandolfi A. J., Sipes I. G., Brown B. R., Jr., Waters S. J. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes. Anesth. Analg. 1986; 65: 835
- Petty R. E., Johnston W., McCormick A. Q., Hunt D. W.C., Rootman J., Rollins D. F. Uveitis and arthritis induced by adjuvant: Clinical, immunologic and histologic characteristics. J. Rheum. 1989; 16: 4
- Hastings K. L., Schuman S., Brown A. P., Thomas C., Gandolfi A. J. S-ethylthiotrifluoroacetate enhancement of the immune response to halothane in the guinea pig. Biological Reactive Intermediates IV, C. M. Witmer. Plenum Press, New York 1991; 739